Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and - 202 A/C IGFBP3 variants an treatment outcomes of children with severe GH deficiency (2011)
- Authors:
- USP affiliated authors: ANTONINI, SONIR ROBERTO RAUBER - FMRP ; MENDONÇA, BERENICE BILHARINHO DE - FM ; JORGE, ALEXANDER AUGUSTO DE LIMA - FM
- Unidades: FMRP; FM
- DOI: 10.1038/tpj.2011.13
- Subjects: FARMACOGENÉTICA; NANISMO; VARIAÇÃO GENÉTICA; HORMÔNIO DO CRESCIMENTO (DEFICIÊNCIA;TERAPIA;USO)
- Language: Inglês
- Imprenta:
- Source:
- Título: The Pharmacogenomics Journal
- ISSN: 1470-269X
- Volume/Número/Paginação/Ano: online, 2011
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
COSTALONGA, Everlayny Fiorot et al. Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and - 202 A/C IGFBP3 variants an treatment outcomes of children with severe GH deficiency. The Pharmacogenomics Journal, 2011Tradução . . Disponível em: https://doi.org/10.1038/tpj.2011.13. Acesso em: 22 jan. 2026. -
APA
Costalonga, E. F., Antonini, S. R. R., Guerra Júnior, G., Coletta, R. R. D., Franca, M. M., Braz, A. F., et al. (2011). Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and - 202 A/C IGFBP3 variants an treatment outcomes of children with severe GH deficiency. The Pharmacogenomics Journal. doi:10.1038/tpj.2011.13 -
NLM
Costalonga EF, Antonini SRR, Guerra Júnior G, Coletta RRD, Franca MM, Braz AF, Mendonça BB de, Arnhold IJP, Jorge AA de L. Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and - 202 A/C IGFBP3 variants an treatment outcomes of children with severe GH deficiency [Internet]. The Pharmacogenomics Journal. 2011 ;[citado 2026 jan. 22 ] Available from: https://doi.org/10.1038/tpj.2011.13 -
Vancouver
Costalonga EF, Antonini SRR, Guerra Júnior G, Coletta RRD, Franca MM, Braz AF, Mendonça BB de, Arnhold IJP, Jorge AA de L. Growth hormone pharmacogenetics: the interactive effect of a microsatellite in the IGF1 promoter region with the GHR-exon 3 and - 202 A/C IGFBP3 variants an treatment outcomes of children with severe GH deficiency [Internet]. The Pharmacogenomics Journal. 2011 ;[citado 2026 jan. 22 ] Available from: https://doi.org/10.1038/tpj.2011.13 - Genetic Predictors of Long-Term Response to Growth Hormone (GH) Therapy in Children With GH Deficiency and Turner Syndrome: the influence of a SOCS2 polymorphism
- High-throughput splicing assays identify missense and silent splice-disruptive POU1F1 variants underlying pituitary hormone deficiency
- Considerable frequency of novel GLI2 missense witations in patientes with hypopituitarism without holoprosencephaly
- Absence of GH-Releasing Hormone (GHRH) Mutations in Selected Patients with Isolated GH Deficiency
- IGF-1 assessed by pubertal status has the best positive predictive power for GH deficiency diagnosis in peripubertal children
- Analyses of the GLI2 Gene in Patients with Congenital Isolated GH Deficiency (IGHD) or Associated to Other Pituitary Hormone Deficiencies (CPHD) Without Holoprosencephaly (HPE)
- The Effect of Transdermic Dihydrotestosterone Gel Treatment on Penile Size: Experience with Fifteen Patients
- Investigação genética
- Novel Mutations in the Growth Hormone Secretagogue Receptor Gene (GHSR) Associated with Constitutional Delay in Growth and Puberty (CDGP)
- Partial recovery of pituitary function linear growth in patients with congenital combined pituitary hormone deficiency (CPHD)
Informações sobre o DOI: 10.1038/tpj.2011.13 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
